Expansion of a BDCA1+CD14+ Myeloid Cell Population in Melanoma Patients May Attenuate the Efficacy of Dendritic Cell Vaccines.

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Cancer Research

• Publication date

  2016-08-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1158/0008-5472.CAN-15-1695PMID 27325645
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Dendritic cell subsets.

  2017cited by this paper
• BubbleGUM: automatic extraction of phenotype molecular signatures and comprehensive visualization of multiple Gene Set Enrichment Analyses

  2015cited by this paper
• Effective Clinical Responses in Metastatic Melanoma Patients after Vaccination with Primary Myeloid Dendritic Cells

  2015cited by this paper
• Paradigm Shift in Dendritic Cell-Based Immunotherapy: From in vitro Generated Monocyte-Derived DCs to Naturally Circulating DC Subsets

  2014cited by this paper
• Mycobacterium tuberculosis promotes Th17 expansion via regulation of human dendritic cells toward a high CD14 and low IL-12p70 phenotype that reprograms upon exogenous IFN-γ.

  2014cited by this paper
• Clinical use of dendritic cells for cancer therapy.

  2014cited by this paper
• Vitamin D3 metabolite calcidiol primes human dendritic cells to promote the development of immunomodulatory IL-10-producing T cells.

  2014cited by this paper
• Human Dermal CD14+ Cells Are a Transient Population of Monocyte-Derived Macrophages

  2014cited by this paper
• The STAT3-Binding Long Noncoding RNA lnc-DC Controls Human Dendritic Cell Differentiation

  2014cited by this paper
• The Nature of Activatory and Tolerogenic Dendritic Cell-Derived Signal 2

  2014cited by this paper
• Natural human plasmacytoid dendritic cells induce antigen-specific T-cell responses in melanoma patients.

  2013cited by this paper
• Tumor-Altered Dendritic Cell Function: Implications for Anti-Tumor Immunity

  2013cited by this paper
• Intradermal application of vitamin D3 increases migration of CD14+ dermal dendritic cells and promotes the development of Foxp3+ regulatory T cells

  2013cited by this paper
• Human inflammatory dendritic cells induce Th17 cell differentiation.

  2013influential reference
• Targeting CD4(+) T-helper cells improves the induction of antitumor responses in dendritic cell-based vaccination.

  2013cited by this paper
• Safety and tumor responses with lambrolizumab (anti-PD-1) in melanoma.

  2013cited by this paper
• Deciphering and reversing tumor immune suppression.

  2013cited by this paper
• The nature of activatory and tolerogenic dendritic cell-derived signal II

  2013cited by this paper
• RNA-seq analysis of prostate cancer in the Chinese population identifies recurrent gene fusions, cancer-associated long noncoding RNAs and aberrant alternative splicings

  2012cited by this paper
• GM-CSF controls nonlymphoid tissue dendritic cell homeostasis but is dispensable for the differentiation of inflammatory dendritic cells.

  2012cited by this paper
• T-regulatory cells: key players in tumor immune escape and angiogenesis.

  2012cited by this paper
• Coordinated regulation of myeloid cells by tumours

  2012cited by this paper
• Resident CD141 (BDCA3)+ dendritic cells in human skin produce IL-10 and induce regulatory T cells that suppress skin inflammation

  2012cited by this paper
• Zbtb46 expression distinguishes classical dendritic cells and their committed progenitors from other immune lineages

  2012cited by this paper
• Safety, activity, and immune correlates of anti-PD-1 antibody in cancer.

  2012cited by this paper
• Safety and activity of anti-PD-L1 antibody in patients with advanced cancer.

  2012influential reference
• Systematic Review of Medical Treatment in Melanoma: Current Status and Future Prospects

  2011cited by this paper
• Chemokine nitration prevents intratumoral infiltration of antigen-specific T cells

  2011cited by this paper
• Immature immunosuppressive CD14+HLA-DR-/low cells in melanoma patients are Stat3hi and overexpress CD80, CD83, and DC-sign.

  2010cited by this paper
• Development of Monocytes, Macrophages, and Dendritic Cells

  2010influential reference
• Tumors induce the formation of suppressor endothelial cells in vivo

  2010cited by this paper
• Differentiation of type 1 T regulatory cells (Tr1) by tolerogenic DC-10 requires the IL-10-dependent ILT4/HLA-G pathway.

  2010influential reference
• Commonly used prophylactic vaccines as an alternative for synthetically produced TLR ligands to mature monocyte-derived dendritic cells.

  2010cited by this paper
• Hypoxia-induced lysyl oxidase is a critical mediator of bone marrow cell recruitment to form the premetastatic niche.

  2009cited by this paper
• Myeloid-derived suppressor cells as regulators of the immune system

  2009cited by this paper
• Induction of Treg by monocyte‐derived DC modulated by vitamin D3 or dexamethasone: Differential role for PD‐L1

  2009cited by this paper
• Increased circulating myeloid-derived suppressor cells correlate with clinical cancer stage, metastatic tumor burden, and doxorubicin–cyclophosphamide chemotherapy

  2008influential reference
• The B7 Family and Cancer Therapy: Costimulation and Coinhibition

  2007cited by this paper
• Identification of a new subset of myeloid suppressor cells in peripheral blood of melanoma patients with modulation by a granulocyte-macrophage colony-stimulation factor-based antitumor vaccine.

  2007cited by this paper
• Proteolytic processing of CXCL 11 by CD 13 / aminopeptidase N impairs CXCR 3 and CXCR 7 binding and signaling and reduces lymphocyte and endothelial cell migration

  2007cited by this paper
• Proteolytic processing of CXCL11 by CD13/aminopeptidase N impairs CXCR3 and CXCR7 binding and signaling and reduces lymphocyte and endothelial cell migration.

  2007cited by this paper
• Normal human dermis contains distinct populations of CD11c+BDCA-1+ dendritic cells and CD163+FXIIIA+ macrophages.

  2007cited by this paper
• Cancer despite immunosurveillance: immunoselection and immunosubversion

  2006cited by this paper
• 9) TM4 Microarray Software Suite

  2006cited by this paper
• CD4+ T Cell Responses Elicited by Different Subsets of Human Skin Migratory Dendritic Cells1

  2005cited by this paper
• From the Cover: Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles

  2005cited by this paper
• CD4 T Cell Responses Elicited by Different Subsets of Human Skin Migratory Dendritic Cells

  2005cited by this paper
• Dendritic cell immunotherapy: mapping the way

  2004cited by this paper
• PGC-1α-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes

  2003cited by this paper
• Faculty Opinions recommendation of PGC-1alpha-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes.

  2003cited by this paper
• TM4: a free, open-source system for microarray data management and analysis.

  2003cited by this paper
• Characterization of human blood dendritic cell subsets.

  2002cited by this paper
• Kinetics of dendritic cell activation: impact on priming of TH1, TH2 and nonpolarized T cells

  2000cited by this paper
• Immunobiology of dendritic cells.

  2000cited by this paper
• Final maturation of dendritic cells is associated with impaired responsiveness to IFN-gamma and to bacterial IL-12 inducers: decreased ability of mature dendritic cells to produce IL-12 during the interaction with Th cells.

  1999cited by this paper
• Characterization of dermal dendritic cells obtained from normal human skin reveals phenotypic and functionally distinctive subsets.

  1993cited by this paper
• Identification and characterization of a novel monocyte subpopulation in human peripheral blood.

  1989cited by this paper

• Identity, Functions, and the Spatiotemporal Maturation of Type 1 Conventional Dendritic Cells

  2025cites this paper
• Extracorporeal photopheresis reduces the T cell stimulatory capacity of human primary blood conventional dendritic cells type 1

  2025cites this paper
• Proteome and Secretome Profiling of the Melanoma-Induced Transition Toward Immune Incompetent Dendritic Cells Reveals Enhanced IDO1, Cathepsin, and Legumain Activity

  2025cites this paper
• Comparing DC subsets in solid tumors: what about DC3s?

  2025cites this paper
• Tissue‐Resident Memory CD8+ T Cells: Differentiation, Phenotypic Heterogeneity, Biological Function, Disease, and Therapy

  2025cites this paper
• Single-Cell Transcriptomic Profile of Innate Cell Populations in Mesenteric Lymph Nodes of Inflammatory Bowel Disease Patients.

  2025cites this paper
• Recent Advances in Our Understanding of Human Inflammatory Dendritic Cells in Human Immunodeficiency Virus Infection

  2025cites this paper
• Intratumoral administration of the immunologic adjuvant AS01B in combination with autologous CD1c (BDCA-1)+/CD141 (BDCA-3)+ myeloid dendritic cells plus ipilimumab and intravenous nivolumab in patients with refractory advanced melanoma

  2024cites this paper
• Inhibition of CSF-1R and IL-6R prevents conversion of cDC2s into immune incompetent tumor-induced DC3s boosting DC-driven therapy potential

  2024cites this paper
• Mannose and Lactobionic Acid in Nasal Vaccination: Enhancing Antigen Delivery via C-Type Lectin Receptors

  2024cites this paper
• Effector Functions of Dendritic Cells in Cancer: Role of Cytotoxicity and Growth Inhibition.

  2024cites this paper
• EP2/EP4 targeting prevents tumor-derived PGE2-mediated immunosuppression in cDC2s.

  2024cites this paper
• Fully closed and automated enrichment of primary blood dendritic cells for cancer immunotherapy.

  2024cites this paper
• cDC2 plasticity and acquisition of a DC3‐like phenotype mediated by IL‐6 and PGE2 in a patient‐derived colorectal cancer organoids model

  2024cites this paper
• Immune signature and phagocytosis of circulating DC subsets in healthy adults during aging.

  2024cites this paper
• Dendritic cell phenotype and function in a 3D co-culture model of patient-derived metastatic colorectal cancer organoids

  2023cites this paper
• Unbiased high-dimensional flow cytometry identified NK and DC immune cell signature in Luminal A-type and triple negative breast cancer

  2023cites this paper
• PGE2‐EP4 signaling steers cDC2 maturation toward the induction of suppressive T‐cell responses

  2023cites this paper
• Detection of dendritic cell subsets in the tumor microenvironment by multiplex immunohistochemistry

  2023cites this paper
• The role of dendritic cells in radiation-induced immune responses.

  2023cites this paper
• Controlling Antigen Fate in Therapeutic Cancer Vaccines by Targeting Dendritic Cell Receptors

  2023cites this paper
• Multi-omics segregate different transcriptomic impacts of anti-IL-17A blockade on type 17 T-cells and regulatory immune cells in psoriasis skin

  2023influential citation
• Saponin-based adjuvants enhance antigen cross-presentation in human CD11c+ CD1c+ CD5− CD163+ conventional type 2 dendritic cells

  2023cites this paper
• Human Dendritic Cell Enrichment and Their Activation of T Cells

  2023cites this paper
• Dendritic cell type 3 arises from Ly6C+ monocyte-dendritic cell progenitors.

  2023cites this paper
• Dendritic Cell Subsets in Melanoma: Pathophysiology, Clinical Prognosis and Therapeutic Exploitation

  2023cites this paper
• Phenotypes and Functions of Human Dendritic Cell Subsets in the Tumor Microenvironment.

  2023cites this paper
• Single-cell sequencing of ascites fluid illustrates heterogeneity and therapy-induced evolution during gastric cancer peritoneal metastasis

  2023cites this paper
• Conventional dendritic cells type 1 are strongly enriched, quiescent and relatively tolerogenic in local inflammatory arthritis

  2023cites this paper
• Functional specialization of specific DC subsets in the synovial fluid of JIA patients

  2022cites this paper
• Monocytes and Macrophages in the Cancer Immunity Cycle

  2022cites this paper
• Dendritic Cells: The Long and Evolving Road towards Successful Targetability in Cancer

  2022cites this paper
• Dendritic Cell Vaccines: A Promising Approach in the Fight against Ovarian Cancer

  2022influential citation
• The Role of Type-2 Conventional Dendritic Cells in the Regulation of Tumor Immunity

  2022influential citation
• Human dendritic cells in cancer

  2022cites this paper
• Dual Effect of Immune Cells within Tumour Microenvironment: Pro- and Anti-Tumour Effects and Their Triggers

  2022cites this paper
• Human dendritic cell subsets: An updated view of their ontogeny and functional specialization

  2022cites this paper
• Dendritic Cell-Based Immunotherapy in Multiple Myeloma: Challenges, Opportunities, and Future Directions

  2022cites this paper
• How dendritic cells sense and respond to viral infections.

  2021influential citation
• Maturation signatures of conventional dendritic cells in COVID-19 reflect direct viral sensing

  2021cites this paper
• Human CD141+ dendritic cells (cDC1) are impaired in patients with advanced melanoma but can be targeted to enhance anti-PD-1 in a humanized mouse model

  2021cites this paper
• Cancer Vaccines, Adjuvants, and Delivery Systems

  2021cites this paper
• Three distinct tolerogenic CD14+ myeloid cell types to actively manage autoimmune disease: Opportunities and challenges.

  2021cites this paper
• Select hyperactivating NLRP3 ligands enhance the TH1- and TH17-inducing potential of human type 2 conventional dendritic cells

  2021influential citation
• Impaired function and delayed regeneration of dendritic cells in COVID-19

  2021cites this paper
• Genetic variants of EML1 and HIST1H4E in myeloid cell-related pathway genes independently predict cutaneous melanoma-specific survival.

  2021cites this paper
• Systems vaccinology of the BNT162b2 mRNA vaccine in humans

  2021cites this paper
• CD169 Defines Activated CD14+ Monocytes With Enhanced CD8+ T Cell Activation Capacity

  2021cites this paper
• Maturation signatures of conventional dendritic cell subtypes in COVID‐19 suggest direct viral sensing

  2021cites this paper
• CD14 Expressing Precursors Give Rise to Highly Functional Conventional Dendritic Cells for Use as Dendritic Cell Vaccine

  2021influential citation
• Tolerogenic Dendritic Cell-Based Approaches in Autoimmunity

  2021cites this paper
• Uncovering the Depths of the Human Proteome: Antibody-based Technologies for Ultrasensitive Multiplexed Protein Detection and Quantification

  2021cites this paper
• The Therapeutic Potential of Tackling Tumor-Induced Dendritic Cell Dysfunction in Colorectal Cancer

  2021cites this paper
• Immunological responses to adjuvant vaccination with combined CD1c+ myeloid and plasmacytoid dendritic cells in stage III melanoma patients

  2021cites this paper
• International Journal of Medical Science and Current Research (IJMSCR)

  2021cites this paper
• Heterogeneity of exhausted T cells in the tumor microenvironment is linked to patient survival following resection in hepatocellular carcinoma

  2020cites this paper
• Importance of myeloid derived suppressor cells in cancer from a biomarker perspective.

  2020cites this paper
• The role of dendritic cells in tumor microenvironments and their uses as therapeutic targets

  2020cites this paper
• Analysis of canine myeloid-derived suppressor cells (MDSCs) utilizing fluorescence-activated cell sorting, RNA protection mediums to yield quality RNA for single-cell RNA sequencing.

  2020cites this paper
• Inhibition of adjuvant-induced TAM receptors potentiates cancer vaccine immunogenicity and therapeutic efficacy.

  2020cites this paper
• Intratumoral Combinatorial Administration of CD1c (BDCA-1)+ Myeloid Dendritic Cells Plus Ipilimumab and Avelumab in Combination with Intravenous Low-Dose Nivolumab in Patients with Advanced Solid Tumors: A Phase IB Clinical Trial

  2020cites this paper
• Decoding the Heterogeneity of Human Dendritic Cell Subsets.

  2020cites this paper
• IFN-Alpha-Mediated Differentiation of Dendritic Cells for Cancer Immunotherapy: Advances and Perspectives

  2020cites this paper
• Dendritic cells in the tumor microenvironment: prognostic and theranostic impact.

  2020cites this paper
• Subsets of CD1c+ DCs: Dendritic Cell Versus Monocyte Lineage

  2020influential citation
• Identification of FABP5 as an immunometabolic marker in human hepatocellular carcinoma

  2020cites this paper
• Transcriptional and Functional Analysis of CD1c+ Human Dendritic Cells Identifies a CD163+ Subset Priming CD8+CD103+ T Cells

  2020cites this paper
• Functional Role of Dendritic Cell Subsets in Cancer Progression and Clinical Implications

  2020cites this paper
• The quest for faithful in vitro models of human dendritic cells types.

  2020cites this paper
• Dendritic cell subsets and locations.

  2019cites this paper
• Surface LSP-1 Is a Phenotypic Marker Distinguishing Human Classical versus Monocyte-Derived Dendritic Cells

  2019cites this paper
• Novel strategies in dendritic-cell based immunotherapy - Focusing on adjuvant treatment in stage III melanoma

  2019cites this paper
• Neoantigen vaccine: an emerging tumor immunotherapy

  2019cites this paper
• The role of dendritic cells in cancer.

  2019cites this paper
• Human Tumor-Infiltrating Dendritic Cells: From In Situ Visualization to High-Dimensional Analyses

  2019influential citation
• Building on the anti-PD1/PD-L1 backbone: combination immunotherapy for cancer

  2019cites this paper
• Dendritic cell/cytokine‐induced killer cell‐based immunotherapy in lung cancer: What we know and future landscape

  2019cites this paper
• The CD14+HLA-DRlo/neg Monocyte: An Immunosuppressive Phenotype That Restrains Responses to Cancer Immunotherapy

  2019influential citation
• Unleashing Tumour-Dendritic Cells to Fight Cancer by Tackling Their Three A’s: Abundance, Activation and Antigen-Delivery

  2019cites this paper
• Myeloid-Derived Suppressor Cells: Not Only in Tumor Immunity

  2019cites this paper
• The clinical application of cancer immunotherapy based on naturally circulating dendritic cells

  2019cites this paper
• Dendritic Cells and Cancer: From Biology to Therapeutic Intervention

  2019cites this paper
• The tumour microenvironment shapes dendritic cell plasticity in a human organotypic melanoma culture

  2019cites this paper
• Cord-Blood-Stem-Cell-Derived Conventional Dendritic Cells Specifically Originate from CD115-Expressing Precursors

  2019cites this paper
• Are Conventional Type 1 Dendritic Cells Critical for Protective Antitumor Immunity and How?

  2019cites this paper
• Adjustment of dendritic cells to the breast-cancer microenvironment is subset specific

  2018cites this paper
• BDCA1+CD14+ Immunosuppressive Cells in Cancer, a Potential Target?

  2018cites this paper
• A subset of CD1c+ dendritic cells is increased in patients with tuberculosis and promotes Th17 cell polarization.

  2018cites this paper
• Human in vivo-differentiated monocyte-derived dendritic cells.

  2018cites this paper
• Diamonds in the Rough: Harnessing Tumor-Associated Myeloid Cells for Cancer Therapy

  2018cites this paper
• Myeloid cell heterogeneity in cancer: not a single cell alike.

  2018cites this paper
• Les cellules dendritiques inflammatoires humaines utilisent une voie non-cytosolique pour la présentation croisée

  2018cites this paper
• Combination Immunotherapy: Taking Cancer Vaccines to the Next Level

  2018cites this paper
• Enhancement of Antitumor Vaccination by Targeting Dendritic Cell-Related IL-10

  2018cites this paper
• Human dendritic cell subsets: an update

  2018cites this paper
• Tolerogenic Dendritic Cells as a Promising Antigen-Specific Therapy in the Treatment of Multiple Sclerosis and Neuromyelitis Optica From Preclinical to Clinical Trials

  2018cites this paper
• Large-Scale Human Dendritic Cell Differentiation Revealing Notch-Dependent Lineage Bifurcation and Heterogeneity

  2018cites this paper
• LPS-elicited TSLPR expression enriches a functionally discrete subset of human CD14+ CD1c+ monocytes

  2017cites this paper
• Isolation of Mononuclear Cell Populations from Ovarian Carcinoma Ascites.

  2017cites this paper
• Quantitative Pathology Improving Cancer Vaccine Efficacy : Study of a Cell Population Suspected of Counteracting Dendritic Cell Vaccinations using Multiplex and Multispectral Analyses

  2017cites this paper